Hinova Pharmaceuticals Inc.

We endeavor to deliver novel therapies to patients worldwide.

Hinova is one of the fastest growing start-up drug discovery and development companies in China. In addition to HC-1119, which is in Phase III international multi-center trials for prostate cancer, there is also an anti-hyperuricemia and gout drug being developed in Phase I clinical trials in China. Several other projects are in the stages of IND enabling studies and drug discovery.